Facilitating Clinical Manufacturing of Recombinant Proteins with Large-Scale Single-Use Fermentation Technology

Pharma’s Almanac: In conversation with Pharma’s Almanac Editor in Chief David Alvaro, Ph.D., BIOVECTRA’s Scott Doncaster, Neil Morrison, and Cameron Graham discuss the company’s addition of single-use fermenter technology at its site in Windsor, Nova Scotia, Canada. The seamless integration of ABEC’s Custom Single Run (CSR) fermentation solutions with working volumes up to 1,000 liters will enhance BIOVECTRA’s high-growth biologic microbial fermentation processes and provide fast turnaround product-to-product and between batches, providing BIOVECTRA customers with greater flexibility, faster turnaround times, and higher capacity utilization.

Read the article